Hangzhou Danwei Biotechnology Co., Ltd. is a holding subsidiary of the listed company Zhejiang Orient Biotechnology Co., Ltd. and is located in the Health Valley of Hangzhou Future Science and Technology City. Danwei integrates the research, development and production of in vitro diagnostic reagents and instruments globally, and is committed to providing faster, more accurate and innovative solutions in the field of molecular diagnostics. In addition to pursuing world-class standards in the field of in vitro diagnostics and molecules, the company is actively deploying a second-generation sequencing platform and striving to develop and innovate second-generation sequencing technologies. The core of Danwei's business is to serve people and enhance global health by giving people insight into Danwei!